Is BMKDF or DIVO a better dividend investment in 2026?

BMKDF currently yields 457.88% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: BMKDF offers higher current income.

What is the dividend yield difference between BMKDF and DIVO?

BMKDF has a forward dividend yield of 457.88% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 451.39 percentage points.

Home › Compare › BMKDF vs DIVO

BMKDF vs DIVO: Dividend Comparison 2026

BMKDF yields 457.88% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BMKDF wins by $31301.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BMKDF

● Live price

457.88%

Share price

$0.44

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31301.59M

Annual income

$21,894,951,007.12

Full BMKDF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — BMKDF vs DIVO

📍 BMKDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BMKDF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BMKDF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BMKDF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMKDF

Annual income on $10K today (after 15% tax)

$38,919.41/yr

After 10yr DRIP, annual income (after tax)

$18,610,708,356.05/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, BMKDF beats the other by $18,610,707,521.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMKDF + DIVO for your $10,000?

BMKDF: 50%DIVO: 50%

100% DIVO50/50100% BMKDF

Portfolio after 10yr

$15650.81M

Annual income

$10,947,475,994.40/yr

Blended yield

69.95%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMKDF buys

DIVO buys

No recent congressional trades found for BMKDF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBMKDFDIVO

Forward yield	457.88% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$31301.59M ✓	$30.7K
Annual income after 10y	$21,894,951,007.12 ✓	$981.68
Total dividends collected	$30466.21M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BMKDF vs DIVO ($10,000, DRIP)

Year	BMKDF Portfolio	BMKDF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$56,488	$45,787.55	$11,349	$649.42	+$45.1K → BMKDF
2	$302,164	$241,722.06	$12,833	$688.83	+$289.3K → BMKDF
3	$1,531,747	$1,208,431.83	$14,459	$727.90	+$1.52M → BMKDF
4	$7,364,069	$5,725,100.03	$16,238	$766.49	+$7.35M → BMKDF
5	$33,603,058	$25,723,503.90	$18,179	$804.47	+$33.58M → BMKDF
6	$145,655,437	$109,700,164.94	$20,293	$841.71	+$145.64M → BMKDF
7	$600,248,607	$444,397,288.85	$22,591	$878.14	+$600.23M → BMKDF
8	$2,353,825,830	$1,711,559,820.57	$25,087	$913.65	+$2353.80M → BMKDF
9	$8,791,249,606	$6,272,655,967.90	$27,791	$948.18	+$8791.22M → BMKDF
10	$31,301,588,085	$21,894,951,007.12	$30,718	$981.68	+$31301.56M → BMKDF

BMKDF vs DIVO: Complete Analysis 2026

BMKDF — Stock

BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

Full BMKDF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this BMKDF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMKDF vs SCHD BMKDF vs JEPI BMKDF vs O BMKDF vs KO BMKDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.